# Lilly Ventures: portfolio, investments and team > Lilly Ventures is a growth equity based in India. 24 investments on record, latest Jan 2017. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/lilly-ventures-2 (Millionrounds; every figure on the page links to its filing or article) India · [Investor](https://millionrounds.com/investors) # Lilly Ventures Last cheque observed Jan 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Email Quiet Growth equity Series C Series A Series B Venture Capital & Private Equity Follow Lilly Ventures and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Flilly-ventures-2) Cheques on record **0%** of best year **0** **cheques in 12 months**, 24 on record Since the last cheque **3586** days **00** hrs **00** min **00** sec Median round **$26M** Rounds led **0 of 24** Sole investor **2 rounds** Exits **4 from the portfolio** Mostly in **United States, 100%** Pitch Lilly Ventures Another investor of this name exists, and we could not establish from the rounds which of them the press meant. Treat the record below as possibly belonging to either. [Tell us which](https://millionrounds.com/corrections?slug=lilly-ventures-2) if you know. ## Lilly Ventures highlights - 01 24 rounds on record - 02 Mostly Series C and Series A: 61% of its rounds - 03 Sole investor in 2 rounds, median $20M - 04 4 exits from the portfolio ## What they do - **Type:** Growth equity (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Venture Capital & Private Equity - **Based in:** Faridabad, India - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **24 appearances** - **2017** 1 round - **Jan** **[Cavion](https://millionrounds.com/company/cavion)** US · Vcaonline **$26M** With 1 other - **2015** 6 rounds - **Dec** **[Symic Biomedical](https://millionrounds.com/company/symic-biomedical)** Series A · US **$25M** Sole investor - **Mar** **[Aeglea BioTherapeutics](https://millionrounds.com/company/aeglea-biotherapeutics)** Series B · US **$44M** With 4 others - **Mar** **[Nimbus Therapeutics](https://millionrounds.com/company/nimbus-therapeutics)** Series B · US **$43M** With 5 others - **Feb** **[Lysosomal Therapeutics](https://millionrounds.com/company/lysosomal-therapeutics)** Series A · US **$20M** With 6 others - **Jan** **[Surface Oncology](https://millionrounds.com/company/surface-oncology)** Series A · US **$35M** With 3 others - **Jan** **[Symic Biomedical](https://millionrounds.com/company/symic-biomedical)** Series A · US **$15M** Sole investor - **2014** 6 rounds - **Oct** **[Aileron Therapeutics](https://millionrounds.com/company/aileron-therapeutics)** Series E · US **$33M** With 6 others - **Oct** **[Viamet Pharmaceuticals](https://millionrounds.com/company/viamet-pharmaceuticals)** Series D · US **$60M** With 4 others - **Jun** **[Numerate](https://millionrounds.com/company/numerate)** Series C · US **$8.2M** With 1 other - **May** **[Coherus Biosciences](https://millionrounds.com/company/coherus-biosciences)** Series C · US **$55M** With 9 others - **May** **[Lysosomal Therapeutics](https://millionrounds.com/company/lysosomal-therapeutics)** Seed · US **$4.8M** With 6 others - **Jan** **[Aeglea BioTherapeutics](https://millionrounds.com/company/aeglea-biotherapeutics)** Series A · US **$12M** With 5 others - **2008** 1 round - **Mar** **[Hydra Biosciences](https://millionrounds.com/company/hydra-biosciences)** Series C · US **$34M** With 5 others - **2007** 4 rounds - **Nov** **[HemaQuest Pharmaceuticals](https://millionrounds.com/company/hemaquest-pharmaceuticals)** Series A · US **$20M** With 2 others - **Aug** **[MedManage Systems](https://millionrounds.com/company/medmanage-systems)** Series E · US **$5.0M** With 3 others - **Jun** **[Serenex](https://millionrounds.com/company/serenex)** Series D · US **$26M** With 9 others - **Jan** **[Fluidigm](https://millionrounds.com/company/fluidigm)** Series E · US **$37M** With 7 others - **2005** 2 rounds - **Dec** **[GlobeImmune](https://millionrounds.com/company/globeimmune)** Series B · US **$34M** With 7 others - **Oct** **[Serenex](https://millionrounds.com/company/serenex)** Series C · US **$30M** With 5 others - **2004** 3 rounds - **Sept** **[Remon Medical Technologies](https://millionrounds.com/company/remon-medical-technologies)** Series C **$16M** With 4 others - **Apr** **[MedManage Systems](https://millionrounds.com/company/medmanage-systems)** Series C · US **$6.0M** With 2 others - **Jan** **[CGI Pharmaceuticals](https://millionrounds.com/company/cgi-pharmaceuticals)** Series C · US **$22M** With 6 others - **2002** 1 round - **Nov** **[NexCura](https://millionrounds.com/company/nexcura)** Series C · US **$4.0M** With 2 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## Exits from the portfolio Companies it backed that were later bought or listed **4 in all** **[CGI Pharmaceuticals](https://millionrounds.com/company/cgi-pharmaceuticals)** Bought by [Gilead Sciences](https://millionrounds.com/fund/gilead-sciences) **$120M** Jun 2010 **[MedManage Systems](https://millionrounds.com/company/medmanage-systems)** Bought by Physicians Interactive **Undisclosed** Apr 2009 **[Serenex](https://millionrounds.com/company/serenex)** Bought by [Pfizer](https://millionrounds.com/fund/pfizer) **Undisclosed** Mar 2008 **[NexCura](https://millionrounds.com/company/nexcura)** Bought by The Thompson Corporation **Undisclosed** Nov 2005 An exit counts when it came after the firm's first round in the company. From historical deal records. ## The cheque Series C Series A Series B Median round joined **$26M** the round, not its cheque Alone, median **$20M** Led 0 of 24 rounds **0%** - **Sole investor:** 2 rounds - **Last cheque:** Jan 2017 - **Exits:** 4 from the portfolio Rounds by stage said on their site - Series C *8* - Series A *6* - Series B *3* - Series E *3* - Series D *2* - Seed *1* Cheques by year Led Joined 2002 2017 Often in the room with - [Atlas Venture](https://millionrounds.com/fund/atlas-venture) 5 - [Novartis Venture Fund](https://millionrounds.com/fund/novartis-venture-fund) 4 - [Hatteras Venture Partners](https://millionrounds.com/fund/hatteras-venture-partners) 3 - [Intersouth Partners](https://millionrounds.com/fund/intersouth-partners) 3 - [Roche Venture Fund](https://millionrounds.com/fund/roche-venture-fund) 3 - [Versant Ventures](https://millionrounds.com/fund/versant-ventures) 3 **Pitching Lilly Ventures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Lilly Ventures. A count of rooms they were both in, not a relationship either has claimed. [**Atlas Venture** VC firm **5** rounds together](https://millionrounds.com/fund/atlas-venture)[**Novartis Venture Fund** Corporate VC **4** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**Hatteras Venture Partners** VC firm **3** rounds together](https://millionrounds.com/fund/hatteras-venture-partners)[**Intersouth Partners** VC firm **3** rounds together](https://millionrounds.com/fund/intersouth-partners)[**Roche Venture Fund** Corporate VC **3** rounds together](https://millionrounds.com/fund/roche-venture-fund)[**Versant Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/versant-ventures)[**F-Prime Capital** VC firm **2** rounds together](https://millionrounds.com/fund/f-prime)[**Mediphase Venture Partners** VC firm **2** rounds together](https://millionrounds.com/fund/mediphase-venture-partners)[**New Enterprise Associates** VC firm **2** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Partners HealthCare Innovation** Corporate VC **2** rounds together](https://millionrounds.com/fund/partners-healthcare-innovation)[**Polaris Partners** VC firm **2** rounds together](https://millionrounds.com/fund/polaris-partners)[**Ritchie Capital Management** VC firm **2** rounds together](https://millionrounds.com/fund/ritchie-capital-management) ## Recently backed The latest companies Lilly Ventures put money into. [**Cavion** $26M · Jan 2017](https://millionrounds.com/company/cavion) ## Quick answers about Lilly Ventures ### What does Lilly Ventures invest in? Lilly Ventures invests most often at Series C and Series A (61% of the rounds on record), in sectors such as Venture Capital & Private Equity. ### How active is Lilly Ventures? 24 investments on record, 0 of them in the last 12 months. The most recent was in Jan 2017. ### What has Lilly Ventures invested in recently? Its most recent investments on record: Cavion (Undisclosed round, Jan 2017). ### How big are Lilly Ventures's cheques? The median round it joins is $26M. ### Does Lilly Ventures lead rounds? Rarely, if at all: none of its 24 investments on record names it as the lead. ### Where does Lilly Ventures invest? Most of the companies it backs are in the United States (100%). ### Is Lilly Ventures investing now? No investments in the last 12 months; the latest was in Jan 2017. ### Who does Lilly Ventures invest alongside? Most often Atlas Venture (5 rounds together), Novartis Venture Fund (4 rounds together) and Hatteras Venture Partners (3 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=lilly-ventures-2) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=lilly-ventures-2)